Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 5, 2010
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias, M Karina, P Papakostas, et al.
Gynecologic Oncology
|
February 27, 2008
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer
D Pectasides, N Xiros, G Papaxoinis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
H Gogas, A Polyzos, I Stavrinidis, et al.
Anticancer Research
|
August 5, 2006
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data
D Mauri, G Pentheroudakis, D Bafaloukos, et al.
Anticancer Research
|
April 1, 2009
Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1
D Pectasides, G Papaxoinis, M Nikolaou, et al.
Cancer Investigation
|
January 12, 2005
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group
Helen Gogas, D Bafaloukos, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study
G Fountzilas, A Athanassiades, T Giannakakis, et al.
Anticancer Research
|
April 1, 2009
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)
D Pectasides, G Papaxoinis, G Fountzilas, et al.
The Pharmacogenomics Journal
|
September 25, 2013
Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel
A K Koutras, V Kotoula, C Papadimitriou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 29, 2006
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients
S Murray, E Timotheadou, H Linardou, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
February 5, 2010
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias, M Karina, P Papakostas, et al.
Gynecologic Oncology
|
February 27, 2008
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer
D Pectasides, N Xiros, G Papaxoinis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
H Gogas, A Polyzos, I Stavrinidis, et al.
Anticancer Research
|
August 5, 2006
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data
D Mauri, G Pentheroudakis, D Bafaloukos, et al.
Anticancer Research
|
April 1, 2009
Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1
D Pectasides, G Papaxoinis, M Nikolaou, et al.
Cancer Investigation
|
January 12, 2005
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group
Helen Gogas, D Bafaloukos, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study
G Fountzilas, A Athanassiades, T Giannakakis, et al.
Anticancer Research
|
April 1, 2009
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)
D Pectasides, G Papaxoinis, G Fountzilas, et al.
The Pharmacogenomics Journal
|
September 25, 2013
Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel
A K Koutras, V Kotoula, C Papadimitriou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 29, 2006
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients
S Murray, E Timotheadou, H Linardou, et al.
Page
of 13